Intelligent Ultrasound Group (IUG) Competitors

GBX 8.60
+0.25 (+2.99%)
(As of 05/17/2024 ET)

IUG vs. BELL, NCYT, IHC, POLX, C4XD, OBD, RENX, HEMO, OBI, and VRCI

Should you be buying Intelligent Ultrasound Group stock or one of its competitors? The main competitors of Intelligent Ultrasound Group include Belluscura (BELL), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), C4X Discovery (C4XD), Oxford BioDynamics (OBD), Renalytix (RENX), Hemogenyx Pharmaceuticals (HEMO), Ondine Biomedical (OBI), and Verici Dx (VRCI). These companies are all part of the "medical" sector.

Intelligent Ultrasound Group vs.

Intelligent Ultrasound Group (LON:IUG) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intelligent Ultrasound Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Belluscura
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Belluscura has a net margin of 0.00% compared to Intelligent Ultrasound Group's net margin of -23.11%. Intelligent Ultrasound Group's return on equity of -23.58% beat Belluscura's return on equity.

Company Net Margins Return on Equity Return on Assets
Intelligent Ultrasound Group-23.11% -23.58% -12.67%
Belluscura N/A -40.83%-18.19%

Intelligent Ultrasound Group has higher revenue and earnings than Belluscura. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intelligent Ultrasound Group£11.17M2.54-£2.58M-£0.01-867.50
Belluscura£1.20M23.72-£10M-£0.06-287.50

Intelligent Ultrasound Group has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Intelligent Ultrasound Group and Belluscura both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Intelligent Ultrasound GroupN/AN/A
BelluscuraN/AN/A

76.9% of Intelligent Ultrasound Group shares are owned by institutional investors. Comparatively, 15.0% of Belluscura shares are owned by institutional investors. 13.4% of Intelligent Ultrasound Group shares are owned by insiders. Comparatively, 48.1% of Belluscura shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Intelligent Ultrasound Group's average media sentiment score of 0.00 equaled Belluscura'saverage media sentiment score.

Company Overall Sentiment
Intelligent Ultrasound Group Neutral
Belluscura Neutral

Summary

Intelligent Ultrasound Group beats Belluscura on 6 of the 11 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IUG vs. The Competition

MetricIntelligent Ultrasound GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£28.36M£2.16B£5.08B£1.46B
Dividend YieldN/A2.55%37.03%8.54%
P/E Ratio-867.50243.17142.161,751.61
Price / Sales2.54281.792,354.40323,084.75
Price / Cash7.1515.8136.1533.64
Price / Book2.893.425.722.74
Net Income-£2.58M£69.22M£104.88M£179.82M
7 Day Performance-1.27%2.08%1.92%1.16%
1 Month Performance-3.61%3.31%4.19%4.50%
1 Year Performance-26.17%62.70%6.40%9.78%

Intelligent Ultrasound Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BELL
Belluscura
0 of 5 stars
GBX 10.25
flat
N/A-54.3%£16.92M£1.20M-170.8324Gap Down
NCYT
Novacyt
0 of 5 stars
GBX 65
-0.2%
N/A+50.5%£45.91M£7.87M-180.56120
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 16.10
+1.6%
N/A-61.9%£10.99M£41.08M-1,610.00210Positive News
High Trading Volume
POLX
Polarean Imaging
0 of 5 stars
GBX 3.75
-6.3%
N/A-86.4%£8.11M£1.03M-75.0028Gap Down
C4XD
C4X Discovery
0 of 5 stars
GBX 12
+27.3%
N/A-27.3%£30.27M£24.68M300.0049News Coverage
High Trading Volume
OBD
Oxford BioDynamics
0 of 5 stars
GBX 7.90
+0.1%
N/A-55.1%£24.64M£176,000.00-112.8645Analyst Forecast
News Coverage
Gap Up
RENX
Renalytix
0 of 5 stars
GBX 24.50
-3.0%
N/A-72.9%£36.15M£2.41M-68.06102
HEMO
Hemogenyx Pharmaceuticals
0 of 5 stars
GBX 1.56
-1.9%
N/A-31.0%£20.90MN/A-156.0014Gap Up
OBI
Ondine Biomedical
0 of 5 stars
GBX 6.60
flat
N/A-57.8%£18.30M£856,000.00-110.00N/AGap Up
VRCI
Verici Dx
0 of 5 stars
GBX 7.50
flat
N/A-37.3%£18.19MN/A-150.0014

Related Companies and Tools

This page (LON:IUG) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners